Literature DB >> 34315545

Rare paraneoplastic syndrome of prostatic cancer: limbic encephalitis: a case report.

Omar Karray1, Sven Tolner2, Naïm Yarak3, Maguy Cherfan4, Mihaela Dana Cosma4, Walid Sleiman3, Philippe Niclot2, Jean Louis Dubost5, Patrick Coloby3, Stéphane Bart3.   

Abstract

INTRODUCTION: Limbic encephalitis is an autoimmune neurologic disorder, often of paraneoplastic origin, that seldom complicates prostatic tumors. The nonspecificity of symptoms makes the diagnosis sometimes difficult to establish. Prognosis is essentially determined by comorbidities and sensorineural and cognitive sequelae. CLINICAL CASE: A 66-year-old Caucasian patient known to have prostatic small-cell neuroendocrine adenocarcinoma under hormonal therapy developed complex partial epileptic seizures associated with rapidly aggravating severe memory impairment. The tripod of autoimmune limbic encephalitis diagnosis was based on the clinical aspect of brain's functional deterioration, electroencephalography aspect, and γ-aminobutyric acid type B anti-receptor antibody positivity. Clinical, diagnostic, and therapeutic management as well as evolutionary risks were further analyzed.
CONCLUSION: Limbic encephalitis is an extremely rare presentation of neurologic paraneoplastic syndromes. A better knowledge of this entity would help better manage diagnostic and therapeutic difficulties and reduce the risk of possible sequelae.
© 2021. The Author(s).

Entities:  

Keywords:  GABA receptors; Limbic encephalitis; Prostatic neoplasms; Seizures

Year:  2021        PMID: 34315545     DOI: 10.1186/s13256-021-02975-3

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  2 in total

1.  Paraneoplastic limbic encephalitis associated with small cell carcinoma of the prostate.

Authors:  R C Stern; C M Hulette
Journal:  Mod Pathol       Date:  1999-08       Impact factor: 7.842

2.  Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.

Authors:  C Alberti
Journal:  G Chir       Date:  2010 Nov-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.